Clinical trial
Combination Chemotherapy in Treating Patients With Colorectal Cancer
NCT00039208 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00039208 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Colorectal Cancer |
| Official title | Time Finding Study of Chronomodulated Irinotecan, 5 Fluorouracil, Leucovorin and Oxaliplatin as First or Second Chemotherapy Line Against Metastatic Colorectal Cancer |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | fluorouracil, irinotecan hydrochloride, leucovorin calcium, oxaliplatin |
| Start date | Feb 1, 2002 |
| Primary completion | Aug 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 13, 2012 |
| Countries | Belgium, France, Italy, Portugal |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: